Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey
Purpose Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods A total of 68...
Uloženo v:
| Vydáno v: | Cancer causes & control Ročník 28; číslo 2; s. 127 - 136 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Cham
Springer Science + Business Media
01.02.2017
Springer International Publishing Springer Nature B.V |
| Témata: | |
| ISSN: | 0957-5243, 1573-7225 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Purpose
Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question.
Methods
A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components.
Results
After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively (
p
-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33),
p
-trend = 0.002 and 1.34 (1.04–1.74),
p
-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality.
Conclusion
Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality. |
|---|---|
| AbstractList | Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods: A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results: After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03-1.59), 1.24 (0.96-1.60), and 1.87 (1.34-2.63), respectively (p-trend=0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19-2.33), p-trend=0.002 and 1.34 (1.04-1.74), p-trend=0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion: Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality. PURPOSEAlthough metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question.METHODSA total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components.RESULTSAfter adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03-1.59), 1.24 (0.96-1.60), and 1.87 (1.34-2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19-2.33), p-trend = 0.002 and 1.34 (1.04-1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality.CONCLUSIONOur study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality. Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03-1.59), 1.24 (0.96-1.60), and 1.87 (1.34-2.63), respectively (p-trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19-2.33), p-trend = 0.002 and 1.34 (1.04-1.74), p-trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality. Purpose Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is associated with total cancer mortality. The present study was carried out to investigate this important question. Methods A total of 687 cancer deaths were identified from 14,916 participants in the third National Health and Nutrition Examination Survey by linking them to the National Death Index database through December 31, 2006. Cox proportional hazards regression was performed to calculate hazard ratios (HR) and 95% confidence intervals (CI) for total cancer mortality in relation to metabolic syndrome and its individual components. Results After adjustment for confounders, a diagnosis of metabolic syndrome was associated with 33% elevated total cancer mortality. Compared with individuals without metabolic syndrome, those with 3, 4 and 5 abnormal components had HRs (95% CIs) of 1.28 (1.03–1.59), 1.24 (0.96–1.60), and 1.87 (1.34–2.63), respectively ( p -trend = 0.0003). Systolic blood pressure and serum glucose were associated with an increased risk of death from total cancer [HR (95% CI) for highest vs. lowest quartiles: 1.67 (1.19–2.33), p -trend = 0.002 and 1.34 (1.04–1.74), p -trend = 0.003, respectively]. Overall null results were obtained for lung cancer mortality. The effects of metabolic syndrome and its components on non-lung cancer mortality were generally similar to, but somewhat larger than, those for total cancer mortality. Conclusion Our study is among the first to reveal that metabolic syndrome is associated with increased total cancer mortality. |
| Author | Gathirua-Mwangi, Wambui G. Murage, Mwangi J. Monahan, Patrick O. Zhang, Jianjun |
| AuthorAffiliation | 2 Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, USA 1 Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA 3 Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA |
| AuthorAffiliation_xml | – name: 3 Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA – name: 1 Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA – name: 2 Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, USA |
| Author_xml | – sequence: 1 givenname: Wambui G. surname: Gathirua-Mwangi fullname: Gathirua-Mwangi, Wambui G. – sequence: 2 givenname: Patrick O. surname: Monahan fullname: Monahan, Patrick O. – sequence: 3 givenname: Mwangi J. surname: Murage fullname: Murage, Mwangi J. – sequence: 4 givenname: Jianjun surname: Zhang fullname: Zhang, Jianjun |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28097473$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1PFDEYxhuDkQX9AzxomnjhMtqP6dfFhBAEE8SDeG46nS7bdabFtkPc_97OLhDkQDw1bX_P2-d9-xyAvRCDA-AtRh8xQuJTxogx0iDMGyRb2uAXYIGZoI0ghO2BBVJMNIy0dB8c5LxGCDFO0CuwTyRSohV0AX59c8V0cfAW5k3oUxwdNKGHJRYzQGuCdQmOMdWdLxvoAywrB69WPvXw0hQfQ8XOnRnKaqu7nEry8zE8_WNGH7YI_DGlW7d5DV4uzZDdm7v1EPz8cnp1ct5cfD_7enJ80VimcGkUqU0tuZMtshZbS51olVFMda2hFre2M4p2sl1SxY3juLfCUNQJK6wivVP0EHze1b2ZutH11oWSzKBvkh9N2uhovP73JviVvo63mlEkMZ0LHN0VSPH35HLRo8_WDYMJLk5ZYymEpFgq_B8ox4xzymVFPzxB13FKdX5bSigiJUOVev_Y_IPr-y-rgNgBNsWck1tq68t2zLUXP2iM9BwOvQuHruHQczj07BU_Ud4Xf05Ddppc2XDt0iPTz4je7UTrXGJ6eKWVXGElOf0LtqrWWg |
| CODEN | CCCNEN |
| CitedBy_id | crossref_primary_10_1186_s13098_018_0398_2 crossref_primary_10_1055_a_1959_3829 crossref_primary_10_1007_s11764_023_01404_2 crossref_primary_10_3390_nu9121366 crossref_primary_10_1002_ijc_31344 crossref_primary_10_1007_s00420_017_1269_0 crossref_primary_10_1186_s13098_020_00598_0 crossref_primary_10_1002_cncr_33407 crossref_primary_10_1016_j_bcp_2023_115550 crossref_primary_10_3389_fendo_2022_1029941 crossref_primary_10_1210_er_2017_00211 crossref_primary_10_3389_fonc_2020_00942 crossref_primary_10_1038_s41409_021_01414_7 crossref_primary_10_1186_s12885_023_11026_7 crossref_primary_10_3390_cancers16183147 crossref_primary_10_3390_genes13091643 crossref_primary_10_1155_2019_6527457 crossref_primary_10_3389_fendo_2022_1090763 crossref_primary_10_2147_DMSO_S301639 crossref_primary_10_4103_shb_shb_72_20 crossref_primary_10_1158_2159_8290_CD_20_0413 crossref_primary_10_1186_s12889_025_21437_9 crossref_primary_10_1055_a_2179_0809 crossref_primary_10_1371_journal_pone_0269550 crossref_primary_10_1055_a_1868_9164 crossref_primary_10_3389_fpubh_2023_1277389 crossref_primary_10_1038_s41598_020_61945_9 crossref_primary_10_4103_jcrt_JCRT_323_19 crossref_primary_10_3390_ph15111329 crossref_primary_10_1016_j_diabres_2018_05_024 crossref_primary_10_1002_cncr_33295 |
| Cites_doi | 10.1007/s10552-009-9492-y 10.1007/s00592-011-0361-2 10.1016/S0140-6736(10)62037-5 10.1161/HYPERTENSIONAHA.111.189258 10.1056/NEJMp030029 10.1007/s10549-009-0603-y 10.2188/jea.JE20100065 10.1038/ejcn.2009.71 10.1158/1055-9965.EPI-12-0485 10.1158/1055-9965.EPI-10-0230 10.1001/archinte.163.4.427 10.1016/S0002-9343(02)01049-5 10.2337/dcS13-2001 10.1016/j.tvjl.2015.07.007 10.1002/ijc.23747 10.1016/j.medici.2016.03.002 10.2337/dc11-1513 10.1159/000351325 10.3322/caac.21254 10.1007/s12020-013-9939-5 10.1111/j.1751-2980.2010.00469.x 10.1146/annurev-med-051613-012328 10.1200/JCO.2014.58.4680 10.1016/j.ejca.2009.01.031 10.1016/j.maturitas.2009.11.018 10.1161/CIRCULATIONAHA.109.192644 10.1007/s10552-004-1050-z 10.2174/1874189400802010001 10.1158/1055-9965.EPI-10-0112 10.1111/apt.12265 10.1056/NEJMoa021423 10.1161/ATVBAHA.111.241927 10.1016/j.canlet.2016.02.006 10.1038/sj.bjc.6601255 10.1093/annonc/mdp344 10.3322/caac.21262 10.1097/GME.0b013e31828ce95d 10.1016/j.metabol.2009.11.019 10.1186/1756-9966-32-9 10.1017/S002966511100320X 10.1200/JCO.2008.19.8937 10.6026/97320630008613 10.1038/nrclinonc.2016.120 10.1007/s10911-013-9303-7 10.3389/fonc.2012.00123 10.1186/1751-0473-3-17 10.1530/JME-13-0217 10.1093/jnci/djv014 |
| ContentType | Journal Article |
| Copyright | Springer International Publishing Switzerland 2017 Cancer Causes & Control is a copyright of Springer, 2017. |
| Copyright_xml | – notice: Springer International Publishing Switzerland 2017 – notice: Cancer Causes & Control is a copyright of Springer, 2017. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7U7 C1K 5PM |
| DOI | 10.1007/s10552-016-0843-1 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Toxicology Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | Toxicology Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1573-7225 |
| EndPage | 136 |
| ExternalDocumentID | PMC5308139 4313371521 28097473 10_1007_s10552_016_0843_1 48691986 |
| Genre | Journal Article |
| GeographicLocations | Indiana United States--US Indianapolis Indiana |
| GeographicLocations_xml | – name: United States--US – name: Indiana – name: Indianapolis Indiana |
| GrantInformation_xml | – fundername: National Cancer Institute grantid: R25 CA117865-07S1; K05CA175048; 3R01CA196243-02S1 funderid: http://dx.doi.org/10.13039/100000054 – fundername: NCI NIH HHS grantid: R01 CA196243 – fundername: NCI NIH HHS grantid: R25 CA117865 – fundername: NCI NIH HHS grantid: T32 CA117865 – fundername: NCI NIH HHS grantid: K05 CA175048 |
| GroupedDBID | --- -~C .86 .VR 04C 06C 06D 0R~ 0VY 199 1N0 203 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AACGO AAHNG AAIAL AAJBT AAJKR AANCE AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBHK ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPLY ABQBU ABSXP ABTEG ABTHY ABTKH ABTLG ABTMW ABUWG ABWNU ABXPI ABXSQ ACAOD ACDTI ACGFS ACHIC ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADIMF ADJJI ADKNI ADKPE ADQXQ ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUPB AEVLU AEXYK AEXZC AEZWR AFBBN AFDZB AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG AQVQM ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN B-. BA0 BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CCPQU CS3 CSCUP DCCCD DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIHBH EIOEI EJD EMB EMOBN EPAXT ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IPSME ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JENOY JLS JPM JSG JST JZLTJ KDC KOV KPH LAK LLZTM M1P M4Y MA- NAPCQ NB0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV ROL RPX RRX RSV S16 S27 S37 S3B SA0 SAP SBY SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 ZMTXR ZOVNA ~A9 ~EX ~KM -4W -5E -5G -BR -EM -Y2 1SB 28- 2P1 2VQ 3SX 3V. 5QI ABQSL ABULA ADINQ ADULT ADYPR AEFIE AFEXP AGGDS BBWZM CAG COF DOOOF EN4 GQ6 HGD HQ3 HTVGU JAAYA JBMMH JHFFW JKQEH JLXEF JSODD KOW N2Q NDZJH OVD R4E RNI RZC RZE RZK S1Z S26 S28 SCLPG T16 TEORI WK6 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8V Z91 AAYXX ABRTQ ADHKG AFFHD AGQPQ CITATION PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. PKEHL PQEST PQUKI PRINS 7X8 7U7 C1K 5PM |
| ID | FETCH-LOGICAL-c591t-92552f6e840cc1cc3e749a959b4a3c14cba93b84f396ae61dc7a30b7c7c92de93 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 41 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000394452100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0957-5243 |
| IngestDate | Tue Nov 04 01:52:27 EST 2025 Tue Oct 07 10:03:57 EDT 2025 Sun Nov 09 14:30:18 EST 2025 Sat Nov 08 17:02:03 EST 2025 Mon Jul 21 05:53:50 EDT 2025 Sat Nov 29 04:22:18 EST 2025 Tue Nov 18 21:10:28 EST 2025 Fri Feb 21 02:32:47 EST 2025 Thu Jun 19 22:29:06 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Obesity Metabolic syndrome Total cancer mortality Epidemiology Lung cancer mortality Non-lung cancer mortality, cohort study |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c591t-92552f6e840cc1cc3e749a959b4a3c14cba93b84f396ae61dc7a30b7c7c92de93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-3688-2466 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5308139 |
| PMID | 28097473 |
| PQID | 1867928850 |
| PQPubID | 31057 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5308139 proquest_miscellaneous_1877831891 proquest_miscellaneous_1861566368 proquest_journals_1867928850 pubmed_primary_28097473 crossref_citationtrail_10_1007_s10552_016_0843_1 crossref_primary_10_1007_s10552_016_0843_1 springer_journals_10_1007_s10552_016_0843_1 jstor_primary_48691986 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-02-01 |
| PublicationDateYYYYMMDD | 2017-02-01 |
| PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Netherlands – name: Dordrecht |
| PublicationSubtitle | An International Journal of Studies of Cancer in Human Populations |
| PublicationTitle | Cancer causes & control |
| PublicationTitleAbbrev | Cancer Causes Control |
| PublicationTitleAlternate | Cancer Causes Control |
| PublicationYear | 2017 |
| Publisher | Springer Science + Business Media Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: Springer Science + Business Media – name: Springer International Publishing – name: Springer Nature B.V |
| References | Gallagher, LeRoith (CR45) 2013; 36 Sridhar, Goodwin (CR49) 2009; 27 Lee, Cho, Park (CR18) 2010; 21 Radisauskas, Kuzmickiene, Milinaviciene, Everatt (CR43) 2016; 52 Alberti, Eckel, Grundy, Zimmet, Cleeman, Donato, Fruchart (CR7) 2009; 120 Bjorge, Lukanova, Jonsson, Tretli, Ulmer, Manjer, Stocks (CR31) 2010; 19 Torre, Bray, Sigel, Ferlay, Lortet-Tieulent, Jemal (CR1) 2015; 65 Emaus, Veierod, Tretli, Finstad, Selmer, Furberg, Bernstein (CR32) 2010; 121 Calle, Rodriguez, Walker-Thurmond, Thun (CR16) 2003; 348 Dal Maso, Zucchetto, Talamini, Serraino, Stocco, Vercelli, Falcini (CR14) 2008; 123 Nago, Ishikawa, Goto, Kayaba (CR21) 2011; 21 Parekh, Lin, Hayes, Albu, Lu-Yao (CR22) 2010; 21 Xiang, Xiong, Cui, Jiang, Xia, Zhao, Li (CR30) 2013; 32 Dankner, Shanik, Keinan-Boker, Cohen, Chetrit (CR41) 2012; 35 Hursting, Hursting (CR48) 2012; 32 Belardi, Gallagher, Novosyadlyy, Leroith (CR50) 2013 Klil-Drori, Azoulay, Pollak (CR51) 2016 Simpson, Brown (CR47) 2013 Colangelo, Gapstur, Gann, Dyer, Liu (CR36) 2002; 11 Demark-Wahnefried, Platz, Ligibel, Blair, Courneya, Meyerhardt, Ganz (CR5) 2012; 21 Esposito, Chiodini, Capuano, Bellastella, Maiorino, Rafaniello, Panagiotakos (CR10) 2013; 44 Hoenerhoff (CR53) 2015; 206 Batty, Shipley, Marmot, Smith (CR35) 2004; 15 Grossman, Messerli, Boyko, Goldbourt (CR40) 2002; 112 Park, Zhu, Palaniappan, Heshka, Carnethon, Heymsfield (CR9) 2003; 163 Suzuki, Saji, Toi (CR46) 2012; 2 Matthews, Sui, LaMonte, Adams, Hebert, Blair (CR38) 2010; 59 Grundmark, Garmo, Loda, Busch, Holmberg, Zethelius (CR29) 2010; 19 Marcus, Prorok, Miller, DeVoto, Kramer (CR39) 2015 Esposito, Chiodini, Capuano, Bellastella, Maiorino, Rafaniello, Giugliano (CR11) 2013; 20 Beigh, Jain (CR26) 2012; 8 Hua, Yu, Hu (CR52) 2016; 374 Batty, Shipley, Marmot, Davey Smith, Whitehall (CR34) 2003; 89 Seidell (CR20) 2010; 64 Bursac, Gauss, Williams, Hosmer (CR25) 2008; 2008 Younossi, Zheng, Stepanova, Venkatesan, Mir (CR28) 2013; 37 Doyle, Donohoe, Lysaght, Reynolds (CR44) 2012; 71 McCullough (CR8) 2011; 12 Siegel, Miller, Jemal (CR2) 2015; 65 Teucher, Rohrmann, Kaaks (CR12) 2010; 65 Jaggers, Sui, Hooker, LaMonte, Matthews, Hand, Blair (CR17) 2009; 45 Finucane, Stevens, Cowan, Danaei, Lin, Paciorek, Singh (CR3) 2011; 377 (CR24) 1994; 1 Lopez-Saez, Martinez-Rubio, Alvarez, Carrera, Dominguez Villar, de Lomas, Domenech (CR33) 2008; 2 Trevisan, Liu, Muti, Misciagna, Menotti, Fucci, Risk (CR37) 2001; 10 CR27 Perseghin, Calori, Lattuada, Ragogna, Dugnani, Garancini, Crosignani (CR42) 2012; 49 Golabek, Bukowczan, Chlosta, Powroznik, Dobruch, Borowka (CR13) 2014; 92 CR23 Ligibel, Alfano, Courneya, Demark-Wahnefried, Burger, Chlebowski, Fabian (CR4) 2014; 32 Goodwin, Stambolic (CR6) 2015; 66 Stocks, Van Hemelrijck, Manjer, Bjorge, Ulmer, Hallmans, Lindkvist (CR19) 2012; 59 Adami, Trichopoulos (CR15) 2003; 348 N Nago (843_CR21) 2011; 21 SL Doyle (843_CR44) 2012; 71 MJ Hoenerhoff (843_CR53) 2015; 206 YZ Xiang (843_CR30) 2013; 32 MM Finucane (843_CR3) 2011; 377 AJ Klil-Drori (843_CR51) 2016 JA Ligibel (843_CR4) 2014; 32 JC Seidell (843_CR20) 2010; 64 KG Alberti (843_CR7) 2009; 120 JR Jaggers (843_CR17) 2009; 45 JS Lee (843_CR18) 2010; 21 G Perseghin (843_CR42) 2012; 49 Z Bursac (843_CR25) 2008; 2008 ZM Younossi (843_CR28) 2013; 37 M Trevisan (843_CR37) 2001; 10 PJ Goodwin (843_CR6) 2015; 66 B Teucher (843_CR12) 2010; 65 JB Lopez-Saez (843_CR33) 2008; 2 EJ Gallagher (843_CR45) 2013; 36 843_CR27 843_CR23 N Parekh (843_CR22) 2010; 21 R Radisauskas (843_CR43) 2016; 52 F Hua (843_CR52) 2016; 374 L Dal Maso (843_CR14) 2008; 123 W Demark-Wahnefried (843_CR5) 2012; 21 EE Calle (843_CR16) 2003; 348 AJ McCullough (843_CR8) 2011; 12 T Golabek (843_CR13) 2014; 92 A Emaus (843_CR32) 2010; 121 LA Colangelo (843_CR36) 2002; 11 R Dankner (843_CR41) 2012; 35 R Suzuki (843_CR46) 2012; 2 GD Batty (843_CR34) 2003; 89 Center for Disease Control and Prevention (843_CR24) 1994; 1 E Grossman (843_CR40) 2002; 112 K Esposito (843_CR10) 2013; 44 E Simpson (843_CR47) 2013 RL Siegel (843_CR2) 2015; 65 B Grundmark (843_CR29) 2010; 19 T Bjorge (843_CR31) 2010; 19 HO Adami (843_CR15) 2003; 348 V Belardi (843_CR50) 2013 T Stocks (843_CR19) 2012; 59 SD Hursting (843_CR48) 2012; 32 SH Beigh (843_CR26) 2012; 8 YW Park (843_CR9) 2003; 163 CE Matthews (843_CR38) 2010; 59 K Esposito (843_CR11) 2013; 20 GD Batty (843_CR35) 2004; 15 LA Torre (843_CR1) 2015; 65 PM Marcus (843_CR39) 2015 SS Sridhar (843_CR49) 2009; 27 23432436 - Aliment Pharmacol Ther. 2013 Apr;37(7):703-9 23546613 - Endocrine. 2013 Dec;44(3):634-47 12711736 - N Engl J Med. 2003 Apr 24;348(17):1623-4 20022719 - Maturitas. 2010 Feb;65(2):112-6 24154546 - J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):277-89 22051112 - Proc Nutr Soc. 2012 Feb;71(1):181-9 19759188 - Ann Oncol. 2010 Mar;21(3):640-5 11927499 - Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):385-91 20647401 - Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2088-96 12711737 - N Engl J Med. 2003 Apr 24;348(17):1625-38 18665244 - Open Clin Cancer J. 2008 Jan 18;2:1-6 23571527 - Menopause. 2013 Dec;20(12):1301-9 22829741 - Bioinformation. 2012;8(13):613-6 25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108 18711698 - Int J Cancer. 2008 Nov 1;123(9):2188-94 20094767 - Cancer Causes Control. 2010 Apr;21(4):631-42 26324636 - Vet J. 2015 Oct;206(1):1-2 25423596 - Annu Rev Med. 2015;66:281-96 11959059 - Am J Med. 2002 Apr 15;112(6):479-86 22695735 - Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1244-59 19087314 - Source Code Biol Med. 2008 Dec 16;3:17 7975354 - Vital Health Stat 1. 1994 Jul;(32):1-407 19805654 - Circulation. 2009 Oct 20;120(16):1640-5 23061041 - Front Oncol. 2012 Oct 04;2:123 23882051 - Diabetes Care. 2013 Aug;36 Suppl 2:S233-9 19250819 - Eur J Cancer. 2009 Jul;45(10):1831-8 21091931 - J Dig Dis. 2011 Oct;12(5):333-40 21160131 - J Epidemiol. 2011;21(1):67-74 26879686 - Cancer Lett. 2016 Apr 28;374(1):54-61 22353615 - Hypertension. 2012 Apr;59(4):802-10 25663695 - J Natl Cancer Inst. 2015 Feb 06;107(4):null 22215126 - Acta Diabetol. 2012 Dec;49(6):421-8 15577289 - Cancer Causes Control. 2004 Nov;15(9):873-81 22815342 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1766-70 22619079 - Diabetes Care. 2012 Jul;35(7):1538-43 24163427 - J Mol Endocrinol. 2013 Nov 26;51(3):T51-9 27502359 - Nat Rev Clin Oncol. 2017 Feb;14 (2):85-99 25273035 - J Clin Oncol. 2014 Nov 1;32(31):3568-74 19064959 - J Clin Oncol. 2009 Jan 10;27(2):165-7 20045534 - Metabolism. 2010 Aug;59(8):1231-9 27170481 - Medicina (Kaunas). 2016;52(2):89-98 23942223 - Urol Int. 2014;92(1):7-14 25559415 - CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 20615887 - Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45 19882245 - Breast Cancer Res Treat. 2010 Jun;121(3):651-60 23406686 - J Exp Clin Cancer Res. 2013 Feb 13;32:9 19639001 - Eur J Clin Nutr. 2010 Jan;64(1):35-41 12588201 - Arch Intern Med. 2003 Feb 24;163(4):427-36 14520454 - Br J Cancer. 2003 Oct 6;89(7):1243-7 11535544 - Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):937-41 21295846 - Lancet. 2011 Feb 12;377(9765):557-67 |
| References_xml | – volume: 21 start-page: 631 year: 2010 end-page: 642 ident: CR22 article-title: Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey publication-title: Cancer Causes Control doi: 10.1007/s10552-009-9492-y – volume: 49 start-page: 421 year: 2012 end-page: 428 ident: CR42 article-title: Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up publication-title: Acta Diabetol doi: 10.1007/s00592-011-0361-2 – volume: 377 start-page: 557 year: 2011 end-page: 567 ident: CR3 article-title: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1million participants publication-title: Lancet doi: 10.1016/S0140-6736(10)62037-5 – volume: 59 start-page: 802 year: 2012 end-page: 810 ident: CR19 article-title: Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.189258 – volume: 348 start-page: 1623 year: 2003 end-page: 1624 ident: CR15 article-title: Obesity and mortality from cancer publication-title: N Engl J Med doi: 10.1056/NEJMp030029 – year: 2013 ident: CR47 article-title: Obesity and breast cancer: role of inflammation and aromatase publication-title: J Mol Endocrinol – volume: 10 start-page: 937 year: 2001 end-page: 941 ident: CR37 article-title: Markers of insulin resistance and colorectal cancer mortality publication-title: Cancer Epidemiol Biomarkers Prev – volume: 121 start-page: 651 year: 2010 end-page: 660 ident: CR32 article-title: Metabolic profile, physical activity, and mortality in breast cancer patients publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0603-y – volume: 21 start-page: 67 year: 2011 end-page: 74 ident: CR21 article-title: Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study publication-title: J Epidemiol doi: 10.2188/jea.JE20100065 – year: 2015 ident: CR39 article-title: Conceptualizing overdiagnosis in cancer screening publication-title: J Natl Cancer Inst – volume: 64 start-page: 35 year: 2010 end-page: 41 ident: CR20 article-title: Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2009.71 – volume: 21 start-page: 1244 year: 2012 end-page: 1259 ident: CR5 article-title: The role of obesity in cancer survival and recurrence publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-12-0485 – volume: 11 start-page: 385 year: 2002 end-page: 391 ident: CR36 article-title: Colorectal cancer mortality and factors related to the insulin resistance syndrome publication-title: Cancer Epidemiol Biomarkers Prev – volume: 19 start-page: 1737 year: 2010 end-page: 1745 ident: CR31 article-title: Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-10-0230 – volume: 163 start-page: 427 year: 2003 end-page: 436 ident: CR9 article-title: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994 publication-title: Arch Intern Med doi: 10.1001/archinte.163.4.427 – volume: 112 start-page: 479 year: 2002 end-page: 486 ident: CR40 article-title: Is there an association between hypertension and cancer mortality? publication-title: Am J Med doi: 10.1016/S0002-9343(02)01049-5 – volume: 36 start-page: S233 issue: Suppl 2 year: 2013 end-page: S239 ident: CR45 article-title: Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer publication-title: Diabetes Care doi: 10.2337/dcS13-2001 – volume: 206 start-page: 1 year: 2015 end-page: 2 ident: CR53 article-title: Inflammation and cancer: Partners in crime publication-title: Vet J doi: 10.1016/j.tvjl.2015.07.007 – volume: 123 start-page: 2188 year: 2008 end-page: 2194 ident: CR14 article-title: Effect of obesity and other lifestyle factors on mortality in women with breast cancer publication-title: Int J Cancer doi: 10.1002/ijc.23747 – volume: 1 start-page: 1 issue: 32 year: 1994 end-page: 407 ident: CR24 article-title: Plan and operation of the third national health and nutrition examination survey, 1988–94. Series 1: programs and collection procedures publication-title: Vital Health Stat – volume: 52 start-page: 89 year: 2016 end-page: 98 ident: CR43 article-title: Hypertension, serum lipids and cancer risk: a review of epidemiological evidence publication-title: Medicina (Kaunas) doi: 10.1016/j.medici.2016.03.002 – volume: 2 start-page: 123 year: 2012 ident: CR46 article-title: Impact of body mass index on breast cancer in accordance with the life-stage of women. Front publication-title: Oncol – volume: 35 start-page: 1538 year: 2012 end-page: 1543 ident: CR41 article-title: Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study publication-title: Diabetes Care doi: 10.2337/dc11-1513 – volume: 92 start-page: 7 year: 2014 end-page: 14 ident: CR13 article-title: Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies publication-title: Urol Int doi: 10.1159/000351325 – volume: 65 start-page: 5 year: 2015 end-page: 29 ident: CR2 article-title: Cancer statistics, 2015 publication-title: CA Cancer J Clin doi: 10.3322/caac.21254 – volume: 44 start-page: 634 year: 2013 end-page: 647 ident: CR10 article-title: Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis publication-title: Endocr doi: 10.1007/s12020-013-9939-5 – volume: 12 start-page: 333 year: 2011 end-page: 340 ident: CR8 article-title: Epidemiology of the metabolic syndrome in the USA publication-title: J Dig Dis doi: 10.1111/j.1751-2980.2010.00469.x – year: 2016 ident: CR51 article-title: Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? publication-title: Nat Rev Clin Oncol – volume: 66 start-page: 281 year: 2015 end-page: 296 ident: CR6 article-title: Impact of the obesity epidemic on cancer publication-title: Annu Rev Med doi: 10.1146/annurev-med-051613-012328 – volume: 32 start-page: 3568 year: 2014 end-page: 3574 ident: CR4 article-title: American Society of Clinical Oncology position statement on obesity and cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.4680 – volume: 45 start-page: 1831 year: 2009 end-page: 1838 ident: CR17 article-title: Metabolic syndrome and risk of cancer mortality in men publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.01.031 – volume: 65 start-page: 112 year: 2010 end-page: 116 ident: CR12 article-title: Obesity: focus on all-cause mortality and cancer publication-title: Maturitas doi: 10.1016/j.maturitas.2009.11.018 – volume: 120 start-page: 1640 year: 2009 end-page: 1645 ident: CR7 article-title: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 2008 start-page: 3 year: 2008 ident: CR25 article-title: Purposeful selection of variables in logistic regression publication-title: Source Code Biol Med – ident: CR27 – volume: 15 start-page: 873 year: 2004 end-page: 881 ident: CR35 article-title: Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study publication-title: Cancer Causes Control doi: 10.1007/s10552-004-1050-z – ident: CR23 – volume: 2 start-page: 1 year: 2008 end-page: 6 ident: CR33 article-title: Metabolic profile of breast cancer in a population of women in southern Spain publication-title: Open Clin Cancer J doi: 10.2174/1874189400802010001 – volume: 19 start-page: 2088 year: 2010 end-page: 2096 ident: CR29 article-title: The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-10-0112 – volume: 37 start-page: 703 year: 2013 end-page: 709 ident: CR28 article-title: Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12265 – volume: 348 start-page: 1625 year: 2003 end-page: 1638 ident: CR16 article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults publication-title: N Engl J Med doi: 10.1056/NEJMoa021423 – volume: 32 start-page: 1766 year: 2012 end-page: 1770 ident: CR48 article-title: Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.241927 – volume: 374 start-page: 54 year: 2016 end-page: 61 ident: CR52 article-title: Diabetes and cancer, common threads and missing links publication-title: Cancer Lett doi: 10.1016/j.canlet.2016.02.006 – volume: 89 start-page: 1243 year: 2003 end-page: 1247 ident: CR34 article-title: Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601255 – volume: 21 start-page: 640 year: 2010 end-page: 645 ident: CR18 article-title: Metabolic syndrome and cancer-related mortality among Korean men and women publication-title: Ann Oncol doi: 10.1093/annonc/mdp344 – volume: 65 start-page: 5 year: 2015 end-page: 29 ident: CR1 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin doi: 10.3322/caac.21262 – volume: 20 start-page: 1301 year: 2013 end-page: 1309 ident: CR11 article-title: Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis publication-title: Menopause doi: 10.1097/GME.0b013e31828ce95d – volume: 59 start-page: 1231 year: 2010 end-page: 1239 ident: CR38 article-title: Metabolic syndrome and risk of death from cancers of the digestive system publication-title: Metabolism doi: 10.1016/j.metabol.2009.11.019 – volume: 32 start-page: 9 year: 2013 ident: CR30 article-title: The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-32-9 – volume: 71 start-page: 181 year: 2012 end-page: 189 ident: CR44 article-title: Visceral obesity, metabolic syndrome, insulin resistance and cancer publication-title: Proc Nutr Soc doi: 10.1017/S002966511100320X – volume: 27 start-page: 165 year: 2009 end-page: 167 ident: CR49 article-title: Insulin-insulin-like growth factor axis and colon cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.8937 – volume: 8 start-page: 613 year: 2012 end-page: 616 ident: CR26 article-title: Prevalence of metabolic syndrome and gender differences publication-title: Bioinformation doi: 10.6026/97320630008613 – year: 2013 ident: CR50 article-title: Insulin and IGFs in Obesity-Related Breast Cancer publication-title: J Mammary Gland Biol Neoplasia – volume: 36 start-page: S233 issue: Suppl 2 year: 2013 ident: 843_CR45 publication-title: Diabetes Care doi: 10.2337/dcS13-2001 – volume: 45 start-page: 1831 year: 2009 ident: 843_CR17 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.01.031 – volume: 37 start-page: 703 year: 2013 ident: 843_CR28 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12265 – volume: 32 start-page: 3568 year: 2014 ident: 843_CR4 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.4680 – year: 2016 ident: 843_CR51 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2016.120 – volume: 65 start-page: 112 year: 2010 ident: 843_CR12 publication-title: Maturitas doi: 10.1016/j.maturitas.2009.11.018 – volume: 65 start-page: 5 year: 2015 ident: 843_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21262 – volume: 44 start-page: 634 year: 2013 ident: 843_CR10 publication-title: Endocr doi: 10.1007/s12020-013-9939-5 – volume: 163 start-page: 427 year: 2003 ident: 843_CR9 publication-title: Arch Intern Med doi: 10.1001/archinte.163.4.427 – volume: 123 start-page: 2188 year: 2008 ident: 843_CR14 publication-title: Int J Cancer doi: 10.1002/ijc.23747 – volume: 59 start-page: 1231 year: 2010 ident: 843_CR38 publication-title: Metabolism doi: 10.1016/j.metabol.2009.11.019 – volume: 374 start-page: 54 year: 2016 ident: 843_CR52 publication-title: Cancer Lett doi: 10.1016/j.canlet.2016.02.006 – volume: 59 start-page: 802 year: 2012 ident: 843_CR19 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.111.189258 – volume: 21 start-page: 631 year: 2010 ident: 843_CR22 publication-title: Cancer Causes Control doi: 10.1007/s10552-009-9492-y – volume: 27 start-page: 165 year: 2009 ident: 843_CR49 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.8937 – volume: 21 start-page: 640 year: 2010 ident: 843_CR18 publication-title: Ann Oncol doi: 10.1093/annonc/mdp344 – volume: 21 start-page: 1244 year: 2012 ident: 843_CR5 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-12-0485 – volume: 11 start-page: 385 year: 2002 ident: 843_CR36 publication-title: Cancer Epidemiol Biomarkers Prev – volume: 121 start-page: 651 year: 2010 ident: 843_CR32 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0603-y – volume: 32 start-page: 9 year: 2013 ident: 843_CR30 publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-32-9 – volume: 112 start-page: 479 year: 2002 ident: 843_CR40 publication-title: Am J Med doi: 10.1016/S0002-9343(02)01049-5 – volume: 1 start-page: 1 issue: 32 year: 1994 ident: 843_CR24 publication-title: Vital Health Stat – volume: 92 start-page: 7 year: 2014 ident: 843_CR13 publication-title: Urol Int doi: 10.1159/000351325 – volume: 348 start-page: 1623 year: 2003 ident: 843_CR15 publication-title: N Engl J Med doi: 10.1056/NEJMp030029 – volume: 66 start-page: 281 year: 2015 ident: 843_CR6 publication-title: Annu Rev Med doi: 10.1146/annurev-med-051613-012328 – volume: 64 start-page: 35 year: 2010 ident: 843_CR20 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2009.71 – year: 2013 ident: 843_CR50 publication-title: J Mammary Gland Biol Neoplasia doi: 10.1007/s10911-013-9303-7 – ident: 843_CR23 – volume: 19 start-page: 1737 year: 2010 ident: 843_CR31 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-10-0230 – volume: 20 start-page: 1301 year: 2013 ident: 843_CR11 publication-title: Menopause doi: 10.1097/GME.0b013e31828ce95d – ident: 843_CR27 – volume: 12 start-page: 333 year: 2011 ident: 843_CR8 publication-title: J Dig Dis doi: 10.1111/j.1751-2980.2010.00469.x – volume: 2 start-page: 123 year: 2012 ident: 843_CR46 publication-title: Oncol doi: 10.3389/fonc.2012.00123 – volume: 52 start-page: 89 year: 2016 ident: 843_CR43 publication-title: Medicina (Kaunas) doi: 10.1016/j.medici.2016.03.002 – volume: 65 start-page: 5 year: 2015 ident: 843_CR2 publication-title: CA Cancer J Clin doi: 10.3322/caac.21254 – volume: 71 start-page: 181 year: 2012 ident: 843_CR44 publication-title: Proc Nutr Soc doi: 10.1017/S002966511100320X – volume: 206 start-page: 1 year: 2015 ident: 843_CR53 publication-title: Vet J doi: 10.1016/j.tvjl.2015.07.007 – volume: 8 start-page: 613 year: 2012 ident: 843_CR26 publication-title: Bioinformation doi: 10.6026/97320630008613 – volume: 2008 start-page: 3 year: 2008 ident: 843_CR25 publication-title: Source Code Biol Med doi: 10.1186/1751-0473-3-17 – volume: 15 start-page: 873 year: 2004 ident: 843_CR35 publication-title: Cancer Causes Control doi: 10.1007/s10552-004-1050-z – volume: 21 start-page: 67 year: 2011 ident: 843_CR21 publication-title: J Epidemiol doi: 10.2188/jea.JE20100065 – year: 2013 ident: 843_CR47 publication-title: J Mol Endocrinol doi: 10.1530/JME-13-0217 – volume: 19 start-page: 2088 year: 2010 ident: 843_CR29 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-10-0112 – volume: 32 start-page: 1766 year: 2012 ident: 843_CR48 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.241927 – volume: 89 start-page: 1243 year: 2003 ident: 843_CR34 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601255 – volume: 348 start-page: 1625 year: 2003 ident: 843_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa021423 – volume: 377 start-page: 557 year: 2011 ident: 843_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(10)62037-5 – volume: 120 start-page: 1640 year: 2009 ident: 843_CR7 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – year: 2015 ident: 843_CR39 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djv014 – volume: 49 start-page: 421 year: 2012 ident: 843_CR42 publication-title: Acta Diabetol doi: 10.1007/s00592-011-0361-2 – volume: 35 start-page: 1538 year: 2012 ident: 843_CR41 publication-title: Diabetes Care doi: 10.2337/dc11-1513 – volume: 2 start-page: 1 year: 2008 ident: 843_CR33 publication-title: Open Clin Cancer J doi: 10.2174/1874189400802010001 – volume: 10 start-page: 937 year: 2001 ident: 843_CR37 publication-title: Cancer Epidemiol Biomarkers Prev – reference: 27502359 - Nat Rev Clin Oncol. 2017 Feb;14 (2):85-99 – reference: 22215126 - Acta Diabetol. 2012 Dec;49(6):421-8 – reference: 11535544 - Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):937-41 – reference: 21091931 - J Dig Dis. 2011 Oct;12(5):333-40 – reference: 19064959 - J Clin Oncol. 2009 Jan 10;27(2):165-7 – reference: 22619079 - Diabetes Care. 2012 Jul;35(7):1538-43 – reference: 12711737 - N Engl J Med. 2003 Apr 24;348(17):1625-38 – reference: 19805654 - Circulation. 2009 Oct 20;120(16):1640-5 – reference: 20045534 - Metabolism. 2010 Aug;59(8):1231-9 – reference: 19639001 - Eur J Clin Nutr. 2010 Jan;64(1):35-41 – reference: 23571527 - Menopause. 2013 Dec;20(12):1301-9 – reference: 19250819 - Eur J Cancer. 2009 Jul;45(10):1831-8 – reference: 25423596 - Annu Rev Med. 2015;66:281-96 – reference: 18665244 - Open Clin Cancer J. 2008 Jan 18;2:1-6 – reference: 23882051 - Diabetes Care. 2013 Aug;36 Suppl 2:S233-9 – reference: 23942223 - Urol Int. 2014;92(1):7-14 – reference: 26324636 - Vet J. 2015 Oct;206(1):1-2 – reference: 20094767 - Cancer Causes Control. 2010 Apr;21(4):631-42 – reference: 7975354 - Vital Health Stat 1. 1994 Jul;(32):1-407 – reference: 22815342 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1766-70 – reference: 22353615 - Hypertension. 2012 Apr;59(4):802-10 – reference: 14520454 - Br J Cancer. 2003 Oct 6;89(7):1243-7 – reference: 22695735 - Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1244-59 – reference: 20022719 - Maturitas. 2010 Feb;65(2):112-6 – reference: 12588201 - Arch Intern Med. 2003 Feb 24;163(4):427-36 – reference: 25651787 - CA Cancer J Clin. 2015 Mar;65(2):87-108 – reference: 11959059 - Am J Med. 2002 Apr 15;112(6):479-86 – reference: 25559415 - CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 – reference: 15577289 - Cancer Causes Control. 2004 Nov;15(9):873-81 – reference: 19759188 - Ann Oncol. 2010 Mar;21(3):640-5 – reference: 21295846 - Lancet. 2011 Feb 12;377(9765):557-67 – reference: 20615887 - Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45 – reference: 12711736 - N Engl J Med. 2003 Apr 24;348(17):1623-4 – reference: 18711698 - Int J Cancer. 2008 Nov 1;123(9):2188-94 – reference: 24163427 - J Mol Endocrinol. 2013 Nov 26;51(3):T51-9 – reference: 23432436 - Aliment Pharmacol Ther. 2013 Apr;37(7):703-9 – reference: 20647401 - Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2088-96 – reference: 25663695 - J Natl Cancer Inst. 2015 Feb 06;107(4):null – reference: 11927499 - Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):385-91 – reference: 22829741 - Bioinformation. 2012;8(13):613-6 – reference: 21160131 - J Epidemiol. 2011;21(1):67-74 – reference: 22051112 - Proc Nutr Soc. 2012 Feb;71(1):181-9 – reference: 23546613 - Endocrine. 2013 Dec;44(3):634-47 – reference: 19087314 - Source Code Biol Med. 2008 Dec 16;3:17 – reference: 24154546 - J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):277-89 – reference: 27170481 - Medicina (Kaunas). 2016;52(2):89-98 – reference: 25273035 - J Clin Oncol. 2014 Nov 1;32(31):3568-74 – reference: 23406686 - J Exp Clin Cancer Res. 2013 Feb 13;32:9 – reference: 19882245 - Breast Cancer Res Treat. 2010 Jun;121(3):651-60 – reference: 23061041 - Front Oncol. 2012 Oct 04;2:123 – reference: 26879686 - Cancer Lett. 2016 Apr 28;374(1):54-61 |
| SSID | ssj0005620 |
| Score | 2.4011884 |
| Snippet | Purpose
Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic... Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic disorder is... Purpose Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic... PURPOSEAlthough metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic... Purpose: Although metabolic syndrome incidence has substantially increased during the last few decades, it largely remains unclear whether this metabolic... |
| SourceID | pubmedcentral proquest pubmed crossref springer jstor |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 127 |
| SubjectTerms | Adult Aged Biomedical and Life Sciences Biomedicine Blood Glucose Blood Pressure Cancer Research Databases, Factual Epidemiology Female Hematology Humans Incidence Lung cancer Male Metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - mortality Middle Aged Mortality Neoplasms - blood Neoplasms - mortality Nutrition Nutrition Surveys Obesity Oncology ORIGINAL PAPER Prostate Public Health Risk Factors Triglycerides - blood Waist Circumference - physiology Womens health Young Adult |
| SummonAdditionalLinks | – databaseName: Public Health Database dbid: 8C1 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BQagS4lFoCRRkJE6gCCd2_DghVLXi0hUSReotciaOumrJlmy2gn-P7Thpl8deuEXJOHEyn-0Zz-QbgDd5YSlFiw68VZFyzUVqeGFSi0yLrEGpEEOxCTmbqdNT_TluuC1jWuU4J4aJul6g3yN_74nXdK5UQT9cfk991SgfXY0lNG7DnSyn3A9MdXAjxUMMtIy6kM7h4myMag6_zhWFT0oQntmUpdnaujSkJv7N6Pwzd_K3AGpYl44e_u8bPYIH0SIlHwcIPYZbtt2Be8cx5r4D94edPTL8sPQEzo9t75DjT410B8S0NekXzo4n6FHUkW_BqncWPpm3xNmY5ORs3tUksnBfxJuFdrOxHgA5_GF8Yk44_rLqruzPp_D16PDk4FMaSzakWOisT7XzUPJGWOc2ImaIzEqujS50xQ3DjGNlNKsUbxwSjBVZjdIwWkmUqPPaarYLW-2itc-AKKost02ljHMRad1UqBi1WtSmkZzXJgE6KqzEyGfuy2pclNdMzF7Hpc9h8zouswTeTk0uBzKPTcK7AQWTJFdCZ1qJBPZHfZZxwC_La2Um8Hq67Iaqj7-Y1i5WQcZ7y0yoTTJSKjfPavf8vQFpUwdyRb33xxKQaxicBDxV-PqVdn4WKMML5kw_phN4N6L1Rtf_9QWeb37RF7CdexsnpLDvw1bfrexLuItX_XzZvQoj8RfdhToW priority: 102 providerName: ProQuest |
| Title | Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey |
| URI | https://www.jstor.org/stable/48691986 https://link.springer.com/article/10.1007/s10552-016-0843-1 https://www.ncbi.nlm.nih.gov/pubmed/28097473 https://www.proquest.com/docview/1867928850 https://www.proquest.com/docview/1861566368 https://www.proquest.com/docview/1877831891 https://pubmed.ncbi.nlm.nih.gov/PMC5308139 |
| Volume | 28 |
| WOSCitedRecordID | wos000394452100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1573-7225 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0005620 issn: 0957-5243 databaseCode: 7RV dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1573-7225 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0005620 issn: 0957-5243 databaseCode: BENPR dateStart: 19990101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1573-7225 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0005620 issn: 0957-5243 databaseCode: 7X7 dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1573-7225 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0005620 issn: 0957-5243 databaseCode: 8C1 dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Contemporary customDbUrl: eissn: 1573-7225 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005620 issn: 0957-5243 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_BhtAkxMdgIzAqI_EEipTE348wdeJl1dSNqW-Rc3G0ipGiNJ3gv8d2km6FMQlerCg-J479s32XO_8M8C7jNknQogNvwWOmmYgN4ya2SLVIK5QKMRw2IScTNZvpk34f93KIdh9ckmGmvrHZjXMfRiA8FymNncmz7VY75Ufj9PT8Oq5DdFyMmktnZTE6uDJve8TGYtTFI96maf4ZMPmb1zQsRkdP_usznsLjXvckHzuwPIN7tt6Fh8e9d30XHnX_8Ei3Nek5fD22rcOIvzUQGxBTl6RdOI2doMdLQ74F_d3p8mReE6dNkrOLeVOSnm_7sn9YKDcZmP_J-IfxITjh-nTVXNmfL-DL0fjs8HPcH84QI9dpG2tni2SVsM5AREwRqZVMG811wQzFlGFhNC0Uq1yfGyvSEqWhSSFRos5Kq-kebNWL2r4EohJlma0KZZwxmJRVgYomVovSVJKx0kSQDL2UY89c7g_QuMyvOZd9o-Y-Ws03ap5G8H5d5HtH23GX8F7o-rUkU0KnWokIDgYs5P3QXuaeAVBnSvEkgrfrbDcovafF1HaxCjLeLqZC3SUjpXIzqnbv3-_gta5AphJv59EI5Abw1gKeFHwzp55fBHJwTp2SR3UEHwb43aj631rg1T9Jv4adzCs3IXb9ALbaZmXfwAO8aufLZgT35fTcpzMZUuVSdZiOYPvTeHIyHYXR-gvUtzTM |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQES4lEoBAoYCS6giCR2YvuAECqtWrW7QmKRekudiaOuKNmyj0L_FL8Rj5Nsuzz21gO3aOMkTvab8Xz2-BuAF0lqowgtOvAWaSi0yEIjUhNa5DqLK5QK0RebkP2-OjjQH1fgZ7cXhtIqO5_oHXU5Qpojf0PCazpRKo3enXwLqWoUra52JTQaWOzZs--Osk3e7n5w_-_LJNneGmzuhG1VgRBTHU9D7YLopMqsYzaIMSK3UmijU10IwzEWWBjNCyUq11ljs7hEaXhUSJSok9KS-JJz-VdIyY7Intq8kFKSNTKQOpWO4AneraI2W_XcYx1xz0hJlYfxwjjYpEL-Lcj9M1fztwVbPw5u3_7fvuAduNVG3Ox9YyJ3YcXWa3Ct1-YUrMHNZuaSNRuy7sGXnp06y6CfOjkHZuqSTUeOpzAkKxmzr561OAbDhjVzMTQbHA3HJWtVxo_bm_nr-l29A7b1w1DikT_-NBuf2rP78PlSXn0dVutRbR8CU5GywlaFMo4CR2VVoOKR1VlpKilEaQKIOoDk2Oq1U9mQ4_xcaZowlVOOHmEqjwN4Nb_kpBErWdZ43aNu3lKoTMdaZQFsdPjJW4c2yc_BE8Dz-Wnnimh9ydR2NPNtaDaAZ2pZGymVG0e0e_6DBtnzDiQqInbLA5ALmJ83ICn0xTP18MhLoqfchbZcB_C6s44LXf_XF3i0_EWfwfWdQW8_39_t7z2GGwnFcz5dfwNWp-OZfQJX8XQ6nIyfei_A4PCyjeYXUtaYCA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBVVIiEehNFDASHABRU1iJ7YPCKG2K6rSVSWK1FtwJo66omTbfRT61_h1jJ1k2-Wxtx64RckksZNvxjP2-BuAl0lqowgtEniLNBRaZKERqQktcp3FFUqF6ItNyH5fHR3pgyX42e2FcWmVnU30hrocopsj33TEazpRKo02qzYt4mC79-70LHQVpNxKa1dOo4HInr34TuHb-O3uNv3rV0nS2znc-hC2FQZCTHU8CTU51EmVWYpyEGNEbqXQRqe6EIZjLLAwmhdKVNRwY7O4RGl4VEiUqJPSOiImMv83JCcUu13qW1fSS7KGElKnkoI9wbsV1WbbHr2WgvjMsaryMJ4bE5u0yL85vH_mbf62eOvHxN7d__lr3oM7rSfO3jeqcx-WbL0KK_ttrsEq3G5mNFmzUesBfN23E9IYd6qjeWCmLtlkSPELQ6c9I_bNRzMU2bBBzci3ZofHg1HJWvbxk_Zh_r5-VweB7fwwLiHJH3-ajs7txUP4fC1dX4PleljbdWAqUlbYqlCGQuOorApUPLI6K00lhShNAFEHlhxbHndXTuQkv2SgdvjKXe6ew1ceB_B6dstpQ2KySHjNI3AmKVSmY62yADY6LOWtoRvnl0AK4MXsMpkot-5kajucehk3S8AztUhGSkXji6b3P2pQPmtAoiIX9fIA5Bz-ZwKOIn3-Sj049lTpKSeXl-sA3nSacqXp__oCjxd39DmskK7kH3f7e0_gVuLcPJ_FvwHLk9HUPoWbeD4ZjEfPvEFg8OW6deYXk4-gzQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+syndrome+and+total+cancer+mortality+in+the+Third+National+Health+and+Nutrition+Examination+Survey&rft.jtitle=Cancer+causes+%26+control&rft.au=Gathirua-Mwangi%2C+Wambui+G&rft.au=Monahan%2C+Patrick+O&rft.au=Murage%2C+Mwangi+J&rft.au=Zhang%2C+Jianjun&rft.date=2017-02-01&rft.eissn=1573-7225&rft.volume=28&rft.issue=2&rft.spage=127&rft_id=info:doi/10.1007%2Fs10552-016-0843-1&rft_id=info%3Apmid%2F28097473&rft.externalDocID=28097473 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0957-5243&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0957-5243&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0957-5243&client=summon |